SNAP Update and ResourcesActualización y recursos de SNAP
On November 1, 2025, the requirements to receive and apply to the Supplemental Nutrition Assistance Program (SNAP) benefits have changed. To see the new policies to request SNAP benefits, click here and/or call 211 for SNAP assistance. Learn more
El 1 de noviembre de 2025, cambiaron los requisitos para recibir y aplicar para los beneficios del Programa de Asistencia Nutricional Suplementaria (SNAP, por sus siglas en inglés). Para consultar las nuevas políticas para aplicar para los beneficios de SNAP, haz clic aquí o llama al 211 para obtener ayuda de SNAP. Aprende Más
Transportation UpdateActualización de transporte
Starting December 15, 2025, SafeRide Health will become the new provider for all member rides to doctor appointments and pharmacy visits. After this date, Texas Children’s Health Plan will no longer use MTM for Non Emergency Medical Transportation (NEMT) services.
For other questions, please call Member Services at the number on the back of your member ID card.
A partir del 15 de diciembre de 2025, SafeRide Health será el nuevo proveedor para todos los viajes de los miembros a citas médicas y visitas a la farmacia. Después de esta fecha, Texas Children’s Health Plan ya no usará MTM para los servicios de Transporte Médico No Urgente (NEMT).
Change in Preferred Drug List Status for Lincosamides/Oxazolidinones/Streptogramins Drug Class
Date: May 9, 2024
Attention: All Providers
Effective date: May 7, 2024
Call to action: Effective May 7, 2024, the Texas Health and Human Services (HHS) removed non-preferred status from generic linezolid suspension products. This is in response to the long term back order of the brand product Zyvox by the manufacturer.
The preferred status of the brand name Zyvox will not change to allow any current stock to be used.
How this impacts providers: The change will allow providers to prescribe the generic without requiring PDL prior authorization at this time and continue accessing necessary medication for their patients.
Please see below for the list of impacted drugs (of note, the approval is NDC-specific):
Preferred Medication NDC
Preferred Medication
Type of Change
Effective Date
00054031950
LINEZOLID 100 MG/5 ML SUSP
Generic now preferred
May 9, 2024
31722086525
LINEZOLID 100 MG/5 ML SUSP
Generic now preferred
May 9, 2024
Next step for Providers: Prescribers are encouraged to proactively obtain a prescription for the preferred alternatives to avoid disruption in patient’s therapy. Prescribers should share this communication with their staff.
